| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 13275 | Null | 0.029142074732756 | -0.0087207999 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.029142074732756 | -0.073578649 |
| NSC 13484 | Null | 0.029142074732756 | 0.21239309 |
| NSC 135073 | WITHACNISTIN | 0.029142074732756 | 0.13626079 |
| NSC 252628 | 1H-Purine, 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)seleno]- | 0.029142074732756 | -0.1517237 |
| NSC 350629 | 2-Propen-1-one, 2-[(dimethylamino)methy]-1-(4- .beta.-D-glucopyranosyloxyphenyl)-, tetraacetate ester | 0.029142074732756 | 0.058965413 |
| NSC 354051 | LISCUNDITRIN | 0.029142074732756 | -0.12838714 |
| NSC 359415 | Null | 0.029142074732756 | -0.19132752 |
| NSC 58574 | Pyrimidine, 2,4,5-trichloro-6-propyl- | 0.029142074732756 | 0.2092218 |
| NSC 603084 | 2-Butene, 2,3-dibromo-1,4-bis[(3,4-dichloro-2,5-dihydro- 2-oxofuran-5-yl)oxy]-, (E)- | 0.029142074732756 | 0.10501509 |